| 10534191
|
Lack of induction by rhinoviruses of systemic type I interferon production or enhanced MxA protein expression during the common cold. |
Eur J Clin Microbiol Infect Dis |
1999 |
Makela MJ;Halminen M;Ruuskanen O;Puhakka T;Pirhonen J;Julkunen I;Ilonen J |
View
More |
| 11142632
|
Spectrum of virus inhibition by consensus interferon YM643. |
Antivir Chem Chemother |
2000 |
Yasuda S;Huffman JH;Smee DF;Sidwell RW;Miyata K |
View
More |
| 16275487
|
Recombinant interferon alpha treatment decreases heart rate variability indices and impairs exercise tolerance in patients with chronic hepatitis. |
Biomed Pharmacother |
2005 |
Takase B;Hamabe A;Uehata A;Hujioka T;Kondo T;Matsui T;Ohsuzu F;Ishihara M |
View
More |
| 16289761
|
New treatment regimes for virus-induced exacerbations of asthma. |
Pulm Pharmacol Ther |
2006 |
Edwards MR;Kebadze T;Johnson MW;Johnston SL |
View
More |
| 16641293
|
Human rhinovirus attenuates the type I interferon response by disrupting activation of interferon regulatory factor 3. |
J Virol |
2006 |
Peng T;Kotla S;Bumgarner RE;Gustin KE |
View
More |
| 17020930
|
Human rhinovirus induces robust IP-10 release by monocytic cells, which is independent of viral replication but linked to type I interferon receptor ligation and STAT1 activation. |
J Leukoc Biol |
2006 |
Korpi-Steiner NL;Bates ME;Lee WM;Hall DJ;Bertics PJ |
View
More |
| 1723372
|
The use of interferon-alpha in virus infections. |
Drugs |
1991 |
Finter NB;Chapman S;Dowd P;Johnston JM;Manna V;Sarantis N;Sheron N;Scott G;Phua S;Tatum PB |
View
More |
| 1750016
|
Prophylactic intranasal alpha 2 interferon and viral exacerbations of chronic respiratory disease. |
Thorax |
1991 |
Wiselka MJ;Nicholson KG;Kent J;Cookson JB;Tyrrell DA |
View
More |
| 18234348
|
Understanding the mechanisms of viral induced asthma: new therapeutic directions. |
Pharmacol Ther |
2008 |
Hansbro NG;Horvat JC;Wark PA;Hansbro PM |
View
More |
| 18272195
|
Attenuation of the type I interferon response in cells infected with human rhinovirus. |
Virology |
2008 |
Kotla S;Peng T;Bumgarner RE;Gustin KE |
View
More |
| 19168696
|
Transforming growth factor-beta enhances rhinovirus infection by diminishing early innate responses. |
Am J Respir Cell Mol Biol |
2009 |
Thomas BJ;Lindsay M;Dagher H;Freezer NJ;Li D;Ghildyal R;Bardin PG |
View
More |
| 19211759
|
Proteinase 2Apro is essential for enterovirus replication in type I interferon-treated cells. |
J Virol |
2009 |
Morrison JM;Racaniello VR |
View
More |
| 19734213
|
The ssRNA genome of human rhinovirus induces a type I IFN response but fails to induce maturation in human monocyte-derived dendritic cells. |
J Immunol |
2009 |
Schrauf C;Kirchberger S;Majdic O;Seyerl M;Zlabinger GJ;Stuhlmeier KM;Sachet M;Seipelt J;Stockl J |
View
More |
| 21224721
|
Human rhinovirus recognition in non-immune cells is mediated by Toll-like receptors and MDA-5, which trigger a synergetic pro-inflammatory immune response. |
Virulence |
2011 |
Triantafilou K;Vakakis E;Richer EA;Evans GL;Villiers JP;Triantafilou M |
View
More |
| 21971992
|
The type I interferon response during viral infections: a "SWOT" analysis. |
Rev Med Virol |
2012 |
Gaajetaan GR;Bruggeman CA;Stassen FR |
View
More |
| 22213737
|
Impaired type I and type III interferon induction and rhinovirus control in human cystic fibrosis airway epithelial cells. |
Thorax |
2012 |
Vareille M;Kieninger E;Alves MP;Kopf BS;Moller A;Geiser T;Johnston SL;Edwards MR;Regamey N |
View
More |
| 23154939
|
Asthma exacerbations: a molecular dichotomy between antiviral and pro-inflammatory responses revealed. |
EMBO Mol Med |
2012 |
Andreakos E |
View
More |
| 23165884
|
Defining critical roles for NF-kappaB p65 and type I interferon in innate immunity to rhinovirus. |
EMBO Mol Med |
2012 |
Bartlett NW;Slater L;Glanville N;Haas JJ;Caramori G;Casolari P;Clarke DL;Message SD;Aniscenko J;Kebadze T;Zhu J;Mallia P;Mizgerd JP;Belvisi M;Papi A;Kotenko SV;Johnston SL;Edwards MR |
View
More |
| 24428709
|
Modulation of airway epithelial antiviral immunity by fungal exposure. |
Am J Respir Cell Mol Biol |
2014 |
Zhu L;Lee B;Zhao F;Zhou X;Chin V;Ling SC;Chen Y |
View
More |
| 24472849
|
IL-15 complexes induce NK- and T-cell responses independent of type I IFN signaling during rhinovirus infection. |
Mucosal Immunol |
2014 |
Jayaraman A;Jackson DJ;Message SD;Pearson RM;Aniscenko J;Caramori G;Mallia P;Papi A;Shamji B;Edwards M;Westwick J;Hansel T;Stanciu LA;Johnston SL;Bartlett NW |
View
More |
| 24636264
|
Viral infections in asthma and COPD. |
Respir Investig |
2014 |
Matsumoto K;Inoue H |
View
More |
| 2543280
|
Ineffectiveness of postexposure prophylaxis of rhinovirus infection with low-dose intranasal alpha 2b interferon in families. |
Antimicrob Agents Chemother |
1989 |
Monto AS;Schwartz SA;Albrecht JK |
View
More |
| 2545792
|
Comparative susceptibility of respiratory viruses to recombinant interferons-alpha 2b and -beta. |
J Interferon Res |
1989 |
Sperber SJ;Hayden FG |
View
More |
| 25459580
|
Asthma: the interplay between viral infections and allergic diseases. |
Immunol Allergy Clin North Am |
2015 |
Rowe RK;Gill MA |
View
More |
| 2551976
|
Ineffectiveness of recombinant interferon-beta serine nasal drops for prophylaxis of natural colds. |
J Infect Dis |
1989 |
Sperber SJ;Levine PA;Sorrentino JV;Riker DK;Hayden FG |
View
More |
| 2552975
|
Use of alpha-2-interferon nasal spray for prophylactic reduction of rhinovirus-induced infection in mission-critical groups. |
Aviat Space Environ Med |
1989 |
Morey WA;Blackwell OG |
View
More |
| 27836899
|
TRAIL signaling is proinflammatory and proviral in a murine model of rhinovirus 1B infection. |
Am J Physiol Lung Cell Mol Physiol |
2017 |
Girkin JL;Hatchwell LM;Collison AM;Starkey MR;Hansbro PM;Yagita H;Foster PS;Mattes J |
View
More |
| 28122977
|
Impact of Type I Interferon on the Safety and Immunogenicity of an Experimental Live-Attenuated Herpes Simplex Virus 1 Vaccine in Mice. |
J Virol |
2017 |
Royer DJ;Carr MM;Chucair-Elliott AJ;Halford WP;Carr DJJ |
View
More |
| 28192616
|
Association of ORMDL3 with rhinovirus-induced endoplasmic reticulum stress and type I Interferon responses in human leucocytes. |
Clin Exp Allergy |
2017 |
Liu YP;Rajamanikham V;Baron M;Patel S;Mathur SK;Schwantes EA;Ober C;Jackson DJ;Gern JE;Lemanske RF Jr;Smith JA |
View
More |
| 28228588
|
Investigation of the Role of Protein Kinase D in Human Rhinovirus Replication. |
J Virol |
2017 |
Guedan A;Swieboda D;Charles M;Toussaint M;Johnston SL;Asfor A;Panjwani A;Tuthill TJ;Danahay H;Raynham T;Mousnier A;Solari R |
View
More |
| 2831814
|
Demonstration of dose-response relationship in seasonal prophylaxis of respiratory infections with alpha-2b interferon. |
Antimicrob Agents Chemother |
1988 |
Monto AS;Albrecht JK;Schwartz SA |
View
More |
| 2834996
|
Intranasal recombinant alfa-2b interferon treatment of naturally occurring common colds. |
Antimicrob Agents Chemother |
1988 |
Hayden FG;Kaiser DL;Albrecht JK |
View
More |
| 2839579
|
Tolerance and efficacy of intranasal administration of recombinant beta serine interferon in healthy adults. |
J Infect Dis |
1988 |
Sperber SJ;Levine PA;Innes DJ;Mills SE;Hayden FG |
View
More |
| 2852485
|
Intranasal tolerance and histopathologic effects of a novel synthetic interferon, rIFN-alpha Con1. |
Antiviral Res |
1988 |
Hayden FG;Innes DJ Jr;Mills SE;Levine PA |
View
More |
| 28576493
|
The suppression of innate immune response by human rhinovirus C. |
Biochem Biophys Res Commun |
2017 |
Pang LL;Yuan XH;Shao CS;Li MZ;Wang Y;Wang HM;Xie GC;Xie ZP;Yuan Y;Zhou DM;Sun XM;Zhang Q;Xin Y;Li DD;Duan ZJ |
View
More |
| 29228279
|
In Vitro Model of Fully Differentiated Human Nasal Epithelial Cells Infected With Rhinovirus Reveals Epithelium-Initiated Immune Responses. |
J Infect Dis |
2018 |
Tan KS;Ong HH;Yan Y;Liu J;Li C;Ong YK;Thong KT;Choi HW;Wang DY;Chow VT |
View
More |
| 29486764
|
Impaired type I interferon regulation in the blood transcriptome of recurrent asthma exacerbations. |
BMC Med Genomics |
2018 |
Gomez JL;Diaz MP;Nino G;Britto CJ |
View
More |
| 2982972
|
Intranasal interferon-alpha 2 prophylaxis of natural respiratory virus infection. |
J Infect Dis |
1985 |
Douglas RM;Albrecht JK;Miles HB;Moore BW;Read R;Worswick DA;Woodward AJ |
View
More |
| 2996687
|
Rhinovirus colds. |
Br Med Bull |
1985 |
Phillpotts RJ;Tyrrell DA |
View
More |
| 2997387
|
Tolerance of one-month intranasal interferon. |
J Med Virol |
1985 |
Scott GM;Onwubalili JK;Robinson JA;Dore C;Secher DS;Cantell K |
View
More |
| 29997212
|
Engineered Oncolytic Poliovirus PVSRIPO Subverts MDA5-Dependent Innate Immune Responses in Cancer Cells. |
J Virol |
2018 |
Walton RW;Brown MC;Sacco MT;Gromeier M |
View
More |
| 3001518
|
Prophylactic efficacy of intranasal alpha 2-interferon against rhinovirus infections in the family setting. |
N Engl J Med |
1986 |
Douglas RM;Moore BW;Miles HB;Davies LM;Graham NM;Ryan P;Worswick DA;Albrecht JK |
View
More |
| 3001519
|
Prevention of natural colds by contact prophylaxis with intranasal alpha 2-interferon. |
N Engl J Med |
1986 |
Hayden FG;Albrecht JK;Kaiser DL;Gwaltney JM Jr |
View
More |
| 3011917
|
Intranasal interferon-alpha 2b for seasonal prophylaxis of respiratory infection. |
J Infect Dis |
1986 |
Monto AS;Shope TC;Schwartz SA;Albrecht JK |
View
More |
| 3014018
|
Interferon-beta ser as prophylaxis against experimental rhinovirus infection in volunteers. |
J Interferon Res |
1986 |
Higgins PG;Al-Nakib W;Willman J;Tyrrell DA |
View
More |
| 3016111
|
Prevention of experimental coronavirus colds with intranasal alpha-2b interferon. |
J Infect Dis |
1986 |
Turner RB;Felton A;Kosak K;Kelsey DK;Meschievitz CK |
View
More |
| 3017203
|
Synergism between anti-rhinovirus antivirals: various human interferons and a number of synthetic compounds. |
Antiviral Res |
1986 |
Ahmad AL;Tyrrell DA |
View
More |
| 3025154
|
The efficacy and tolerance of intranasal interferons: studies at the Common Cold Unit. |
J Antimicrob Chemother |
1986 |
Tyrrell DA |
View
More |
| 3028312
|
[Rhinovirus and acute respiratory infections in infants]. |
Arch Fr Pediatr |
1986 |
Freymuth F;Quibriac M;Petitjean J;Pierre C;Duhamel JF;Denis A;Legoas C |
View
More |
| 30296526
|
Interferon-induced epithelial response to rhinovirus 16 in asthma relates to inflammation and FEV1. |
J Allergy Clin Immunol |
2019 |
Ravi A;Koster J;Dijkhuis A;Bal SM;Sabogal Pineros YS;Bonta PI;Majoor CJ;Sterk PJ;Lutter R |
View
More |
| 31319869
|
MEK inhibition drives anti-viral defence in RV but not RSV challenged human airway epithelial cells through AKT/p70S6K/4E-BP1 signalling. |
Cell Commun Signal |
2019 |
Baturcam E;Vollmer S;Schluter H;Maciewicz RA;Kurian N;Vaarala O;Ludwig S;Cunoosamy DM |
View
More |
| 31693592
|
New immunodeficiency syndromes that help us understand the IFN-mediated antiviral immune response. |
Curr Opin Pediatr |
2019 |
Jing H;Su HC |
View
More |
| 31988324
|
Genetically stable poliovirus vectors activate dendritic cells and prime antitumor CD8 T cell immunity. |
Nat Commun |
2020 |
Mosaheb MM;Dobrikova EY;Brown MC;Yang Y;Cable J;Okada H;Nair SK;Bigner DD;Ashley DM;Gromeier M |
View
More |
| 3215290
|
A study of intranasally administered interferon A (rIFN-alpha 2A) for the seasonal prophylaxis of natural viral infections of the upper respiratory tract in healthy volunteers. |
Epidemiol Infect |
1988 |
Tannock GA;Gillett SM;Gillett RS;Barry RD;Hensley MJ;Herd R;Reid AL;Saunders NA |
View
More |
| 3232968
|
Failure to demonstrate synergy between interferon-alpha and a synthetic antiviral, enviroxime, in rhinovirus infections in volunteers. |
Antiviral Res |
1988 |
Higgins PG;Barrow GI;al-Nakib W;Tyrrell DA;DeLong DC;Lenox-Smith I |
View
More |
| 32383224
|
IgE-mediated regulation of IL-10 and type I IFN enhances rhinovirus-induced Th2 differentiation by primary human monocytes. |
Eur J Immunol |
2020 |
Rowe RK;Pyle DM;Farrar JD;Gill MA |
View
More |
| 3303918
|
Influenza B in households: virus shedding without symptoms or antibody response. |
Am J Epidemiol |
1987 |
Foy HM;Cooney MK;Allan ID;Albrecht JK |
View
More |
| 33194777
|
Natural Killer Cells and Host Defense Against Human Rhinoviruses Is Partially Dependent on Type I IFN Signaling. |
Front Cell Infect Microbiol |
2020 |
van der Heide SL;Xi Y;Upham JW |
View
More |
| 33303556
|
TLR7/8 regulates type I and type III interferon signalling in rhinovirus 1b-induced allergic asthma. |
Eur Respir J |
2021 |
Krug J;Kiefer A;Koelle J;Vuorinen T;Xepapadaki P;Stanic B;Chiriac MT;Akdis M;Zimmermann T;Papadopoulos NG;Finotto S |
View
More |
| 33359650
|
Glucocorticoids impair type I IFN signalling and enhance rhinovirus replication. |
Eur J Pharmacol |
2021 |
Marcellini A;Swieboda D;Guedan A;Farrow SN;Casolari P;Contoli M;Johnston SL;Papi A;Solari R |
View
More |
| 33444702
|
Inhibition of coronavirus infection by a synthetic STING agonist in primary human airway system. |
Antiviral Res |
2021 |
Zhu Q;Zhang Y;Wang L;Yao X;Wu D;Cheng J;Pan X;Liu H;Yan Z;Gao L |
View
More |
| 34160242
|
Rhinovirus Reduces the Severity of Subsequent Respiratory Viral Infections by Interferon-Dependent and -Independent Mechanisms. |
mSphere |
2021 |
Van Leuven JT;Gonzalez AJ;Ijezie EC;Wixom AQ;Clary JL;Naranjo MN;Ridenhour BJ;Miller CR;Miura TA |
View
More |
| 34686207
|
Surfaceome CRISPR screen identifies OLFML3 as a rhinovirus-inducible IFN antagonist. |
Genome Biol |
2021 |
Mei H;Zha Z;Wang W;Xie Y;Huang Y;Li W;Wei D;Zhang X;Qu J;Liu J |
View
More |
| 35116044
|
Editorial: Type I and Type III Interferon Immune Responses in Asthma. |
Front Immunol |
2021 |
Finotto S;Jartti T;Johnston SL |
View
More |
| 3524441
|
Intranasal interferon (rIFN-alpha A, Ro 22-8181) for contact prophylaxis against common cold: a randomized, double-blind and placebo-controlled field study. |
Antiviral Res |
1986 |
Herzog C;Berger R;Fernex M;Friesecke K;Havas L;Just M;Dubach UC |
View
More |
| 35265536
|
Pseudomonas aeruginosa Affects Airway Epithelial Response and Barrier Function During Rhinovirus Infection. |
Front Cell Infect Microbiol |
2022 |
Endres A;Hugel C;Boland H;Hogardt M;Schubert R;Jonigk D;Braubach P;Rohde G;Bellinghausen C |
View
More |
| 36860857
|
Hydrogen peroxide attenuates rhinovirus-induced anti-viral interferon secretion in sinonasal epithelial cells. |
Front Immunol |
2023 |
Lee SH;Han MS;Lee TH;Lee DB;Park JH;Lee SH;Kim TH |
View
More |
| 36895568
|
Emerging role for interferons in respiratory viral infections and childhood asthma. |
Front Immunol |
2023 |
Bosco A |
View
More |
| 37087523
|
Rhinovirus-induced epithelial RIG-I inflammasome suppresses antiviral immunity and promotes inflammation in asthma and COVID-19. |
Nat Commun |
2023 |
Radzikowska U;Eljaszewicz A;Tan G;Stocker N;Heider A;Westermann P;Steiner S;Dreher A;Wawrzyniak P;Ruckert B;Rodriguez-Coira J;Zhakparov D;Huang M;Jakiela B;Sanak M;Moniuszko M;O'Mahony L;Jutel M;Kebadze T;Jackson DJ;Edwards MR;Thiel V;Johnston SL;Akdis CA;Sokolowska M |
View
More |
| 37857661
|
Obesity dysregulates the pulmonary antiviral immune response. |
Nat Commun |
2023 |
Almond M;Farne HA;Jackson MM;Jha A;Katsoulis O;Pitts O;Tunstall T;Regis E;Dunning J;Byrne AJ;Mallia P;Kon OM;Saunders KA;Simpson KD;Snelgrove RJ;Openshaw PJM;Edwards MR;Barclay WS;Heaney LM;Johnston SL;Singanayagam A |
View
More |
| 4081525
|
Prevention from naturally acquired viral respiratory infection by interferon nasal spray. |
Rhinology |
1985 |
Saito H;Takenaka H;Yoshida S;Tsubokawa T;Ogata A;Imanishi F;Imanishi J |
View
More |
| 6089652
|
Intranasal interferon-alpha 2 for prevention of natural rhinovirus colds. |
Antimicrob Agents Chemother |
1984 |
Farr BM;Gwaltney JM Jr;Adams KF;Hayden FG |
View
More |
| 6094684
|
Intranasal lymphoblastoid interferon ("Wellferon") prophylaxis against rhinovirus and influenza virus in volunteers. |
J Interferon Res |
1984 |
Phillpotts RJ;Higgins PG;Willman JS;Tyrrell DA;Freestone DS;Shepherd WM |
View
More |
| 6299242
|
Antibody to human leucocyte interferon may enhance the frequency of rhinovirus isolation. |
Arch Virol |
1983 |
Phillpotts RJ |
View
More |
| 6307140
|
Anti-interferon antibody increases rhinovirus isolation rates from nasal wash specimens containing interferon-alpha 2. |
Antiviral Res |
1983 |
Hayden FG;Gwaltney JM Jr |
View
More |
| 6311914
|
Intranasal interferon alpha 2 for prevention of rhinovirus infection and illness. |
J Infect Dis |
1983 |
Hayden FG;Gwaltney JM Jr |
View
More |
| 6312877
|
An effective dosage regimen for prophylaxis against rhinovirus infection by intranasal administration of HuIFN-alpha 2. |
Antiviral Res |
1983 |
Phillpotts RJ;Scott GM;Higgins PG;Wallace J;Tyrrell DA;Gauci CL |
View
More |
| 6323591
|
Cell and virus sensitivity studies with recombinant human alpha interferons. |
J Interferon Res |
1983 |
Kramer MJ;Dennin R;Kramer C;Jones G;Connell E;Rolon N;Gruarin A;Kale R;Trown PW |
View
More |
| 6381610
|
Intranasal interferon-alpha 2 treatment of experimental rhinoviral colds. |
J Infect Dis |
1984 |
Hayden FG;Gwaltney JM Jr |
View
More |
| 6381611
|
Intranasally applied recombinant leukocyte A interferon in normal volunteers. II. Determination of minimal effective and tolerable dose. |
J Infect Dis |
1984 |
Samo TC;Greenberg SB;Palmer JM;Couch RB;Harmon MW;Johnson PE |
View
More |
| 6400034
|
The clinical application of fibroblast interferon--an overview. |
Med Oncol Tumor Pharmacother |
1984 |
Billiau A |
View
More |
| 6619578
|
Efficacy and tolerance of intranasally applied recombinant leukocyte A interferon in normal volunteers. |
J Infect Dis |
1983 |
Samo TC;Greenberg SB;Couch RB;Quarles J;Johnson PE;Hook S;Harmon MW |
View
More |
| 6742821
|
Pharmacokinetics of intranasally applied medication during a cold. |
Antiviral Res |
1984 |
Phillpotts RJ;Davies HW;Willman J;Tyrrell DA;Higgins PG |
View
More |
| 6763365
|
Trials of interferon in respiratory infections in man. |
Tex Rep Biol Med |
1981 |
Greenberg SB;Harmon MW;Tyrrell DA;Scott GM |
View
More |
